Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 14q32 Duplication Syndrome C4225449
Clinical comparison between 2p13 2 Microdeletion Syndrome and 14q32 Duplication Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
14q32 Duplication Syndrome C4225449
A rare chromosomal disorder where extra genetic material from chromosome 14 is present. It can affect development and cause intellectual disability, distinctive facial features, and other health issues. Management focuses on addressing symptoms with specialized care.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
14q32 Duplication Syndrome C4225449
0-0
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
14q32 Duplication Syndrome C4225449
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
14q32 Duplication Syndrome C4225449
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
14q32 Duplication Syndrome C4225449
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
14q32 Duplication Syndrome C4225449
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
14q32 Duplication Syndrome C4225449
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 14q32-duplication-syndrome-C4225449 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 14q32 Duplication Syndrome C4225449 | Discriminating power |
|---|---|---|---|
| Genetic change | Missing chromosomal segment at 2p13.2 | Extra chromosomal material at 14q32 | High |
| Developmental effects | Variable and gene-dependent; not fully established | May include developmental delay and intellectual disability | Moderate |
| Physical features | No specific pattern established in supplied data | Distinctive facial features may occur | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A deletion involving 2p13.2 is confirmed
The diagnosis depends on the missing segment, not symptoms alone
High
Features are highly variable without a known duplication
The source describes gene-dependent variation rather than a fixed pattern
Moderate
Severity appears substantial
The supplied label is severe, but individual severity still needs clinical assessment
Low
Choose 14q32 Duplication Syndrome C4225449 when
A duplication involving 14q32 is confirmed
Extra material at this region distinguishes it from a deletion
High
Developmental disability and facial differences are present
These are described for the duplication, but are not definitive alone
Moderate
Overall impact appears moderate
The supplied severity label is moderate, though course varies
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 14q32 Duplication Syndrome C4225449 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Copy-number loss at 2p13.2 | Copy-number gain at 14q32 | The direction and location of the change are the main distinction |
| Karyotype | May miss a small deletion | May detect a larger duplication | A normal karyotype does not exclude either condition |
| Targeted confirmation | Confirms the deletion and boundaries | Confirms the duplication and boundaries | Results require genetics clinician interpretation |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established and may be substantial
- Factors
- Deleted genes, associated findings, and available support
14q32 Duplication Syndrome C4225449
- Outcome
- Outcome is not established and may be moderate
- Factors
- Duplication extent, developmental needs, and associated health issues
Time frame: Lifelong congenital condition; exact course not established
Individual assessment outweighs the general severity labels
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Possible but variable; specifics not established Developmental and learning needs may occur Support should follow assessed function, not the label alone |
| Associated health issues | Depend on affected genes and are not fully specified Other health issues may occur No complication rate is established from the supplied data |
| Misclassification | An abnormal finding is not itself a complete diagnosis An abnormal finding is not itself a complete diagnosis Clinical correlation and specialist review are needed |
Patient education highlights
- HighDiagnosis
Only genetic testing can distinguish a 2p13.2 deletion from a 14q32 duplication.
- HighVariability
Features and severity vary; published labels do not predict an individual outcome.
- MediumCare
Management is symptom-focused and may involve developmental, medical, and genetics specialists.